- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models ; volume:137 ; number:3 ; day:5 ; month:2 ; year:2019 ; pages:379-395 ; date:3.2019
Acta neuropathologica ; 137, Heft 3 (5.2.2019), 379-395, 3.2019
- Creator
-
Veys, Lien
Vandenabeele, Marjan
Ortuño-Lizarán, Isabel
Baekelandt, Veerle
Cuenca, Nicolás
Moons, Lieve
De Groef, Lies
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-018-01956-z
- URN
-
urn:nbn:de:101:1-2019032619581393934355
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Veys, Lien
- Vandenabeele, Marjan
- Ortuño-Lizarán, Isabel
- Baekelandt, Veerle
- Cuenca, Nicolás
- Moons, Lieve
- De Groef, Lies
- SpringerLink (Online service)
Other Objects (12)
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease